Harmonization trial on ESR1 testing strategies in ER+/HER2- breast cancer patients: an Italian experience
{{output}}
Aims: To date, ESR1 activating mutations acts as key player to clinically stratify estrogen receptor (ER)+/HER2-advanced breast cancer (BC) patients eligible to novel new generation oral Selective Estrogen Receptor Degraders (SER... ...
